Kanika Ballani, Pharm.D.
Diana Hubulasvili, Pharm.D.
Developed by Amylin Pharmaceuticals, Exenatide (Byetta®) is an incretin mimetic that is used as an adjunctive therapy with metformin, a sulfonylurea or a thiazolidinedione to improve glycemic control …